A simple shot in the arm may soon be able to repair damaged bones and joints anywhere in the body. A recent study conducted by a team at Keele University on injected stem cells may hold the answer to naturally curing injuries without any surgery.
These injectable stem cells can be controlled with a magnet. “Once injected these immature cells can be guided to precisely where their help is needed and encouraged to grow new cartilage and bone, work on mice shows.”
Professor Alicia El Haj believes this could be tested in humans in 5 years with patented technology.
Professor Jon Tobias of the Bone Research Society said, “Stem cells capable of regenerating diseased bones and joints can now be isolated and grow up outside the body, but the difficulty is in getting them to exactly the right place.”
This alternative form of treatment would replace surgery or serious drug intake and is aimed to treat patients with injuries and arthritis. The injection would use a patient’s own stem cell from their bone marrow.
So, get ready, as stem cell shots might be the new flu shot of the future.
Stem Cell Shots Could Treat Injuries and Arthritis in 5 Years
1. Injectable Stem Cell Treatment - Opportunity for medical companies to innovate and disrupt traditional surgical and drug-based treatments for bone and joint injuries.
2. Magnetic Control of Stem Cells - Potential for technology companies to innovate and develop new methods for guiding and directing stem cells to specific locations in the body.
3. Personalized Stem Cell Therapy - Growing demand for medical professionals and companies to personalize treatment options based on a patient's own stem cells from their bone marrow.
1. Medical Industry - Opportunities for medical companies to develop and market new stem cell-based treatments for bone and joint injuries.
2. Technology Industry - Potential for technology companies to collaborate with medical professionals and companies to develop new methods for guiding and directing stem cells.
3. Biotech Industry - Growing demand for biotech companies to produce stem cells for personalized therapy options based on a patient's own bone marrow.